World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
23841
World Ranking
1967
National Ranking
7

Elaine Coustan-Smith publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elaine Coustan-Smith sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 155 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Elaine Coustan-Smith D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elaine Coustan-Smith sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

    Jinghui Zhang;Li Ding;Linda Holmfeldt;Gang Wu

  • Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Charles G. Mullighan;Mihaela Onciu;Frederick G. Behm

  • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;James M. Boyett

  • Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Frederick G. Behm;Frederick G. Behm;Joaquin Sanchez;James M. Boyett;James M. Boyett

  • Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.

    Malek Faham;Jianbiao Zheng;Martin Moorhead;Victoria E. H. Carlton

  • Primary B Cell Immunodeficiencies: Comparisons and Contrasts

    Mary Ellen Conley;A Kerry Dobbs;Dana M Farmer;Sebnem Kilic

  • An essential role for BLNK in human B cell development.

    Yoshiyuki Minegishi;Jurg Rohrer;Elaine Coustan-Smith;Howard M. Lederman

  • Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Frederick G. Behm;Michael L. Hancock

  • Bone marrow-derived stromal cells prevent apoptotic cell death in B- lineage acute lymphoblastic leukemia

    Atsushi Manabe;Elaine Coustan-Smith;Frederick G. Behm;Susana C. Raimondi

  • Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia

    Yoshiyuki Minegishi;Elaine Coustan-Smith;Yui-Hsi Wang;Max D. Cooper

  • Detection of minimal residual disease in acute leukemia by flow cytometry.

    Dario Campana;Elaine Coustan-Smith

  • Mutations in Igα (CD79a) result in a complete block in B-cell development

    Yoshiyuki Minegishi;Elaine Coustan-Smith;Lisa Rapalus;Fügen Ersoy

  • Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia

    Elaine Coustan-Smith;Akira Kitanaka;Ching Hon Pui;Lisa McNinch

  • Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease

    Kathryn G. Roberts;Deqing Pei;Dario Campana;Debbie Payne-Turner

  • Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K

    Mary Ellen Conley;Mary Ellen Conley;A. Kerry Dobbs;Anita M. Quintana;Amma Bosompem

  • Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.

    Natalia Lapteva;April G. Durett;Jiali Sun;Lisa A. Rollins

  • The immunologic detection of minimal residual disease in acute leukemia.

    Dario Campana;Elaine Coustan-Smith;George Janossy

  • Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

    Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;Bassem I. Razzouk

  • Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

    G A M Neale;E Coustan-Smith;P Stow;Q Pan

  • Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia

    Hiroto Inaba;Elaine Coustan-Smith;Xueyuan Cao;Stanley B. Pounds

Frequent Co-Authors

Dario Campana
Dario Campana National University of Singapore
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Jeffrey E. Rubnitz
Jeffrey E. Rubnitz St. Jude Children's Research Hospital
James R. Downing
James R. Downing St. Jude Children's Research Hospital
William E. Evans
William E. Evans St. Jude Children's Research Hospital
John T. Sandlund
John T. Sandlund National Institutes of Health
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital
Frederick G. Behm
Frederick G. Behm University of Illinois at Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Elaine Coustan-Smith